Skip to main content
Innate Pharma logo

Innate Pharma — Investor Relations & Filings

Ticker · IPH ISIN · FR0010331421 LEI · 9695002Y8420ZB8HJE29 PA Manufacturing
Open in API
Filings indexed 1,403 across all filing types
Latest filing 2025-11-28 Share Issue/Capital Cha…
Country FR France
Listing PA IPH

About Innate Pharma

http://www.innate-pharma.com/

Innate Pharma is a clinical-stage, oncology-focused biotechnology company that develops immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system, particularly Natural Killer (NK) cells, to create novel treatments. Its innovative pipeline is composed of antibody-based therapeutics, including first-in-class monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific NK cell engagers based on its proprietary ANKET® platform. Key clinical programs include lacutamab (anti-KIR3DL2), monalizumab (anti-NKG2A) in partnership with AstraZeneca, and a portfolio of NK cell engagers targeting various hematological malignancies and solid tumors.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Share Issue/Capital Change Classification · 1% confidence The document is a formal notification of the total number of shares and voting rights as of a specific date (November 27, 2025). This is a standard regulatory disclosure required by French law (Article L. 233-8 II of the Code de Commerce and Article 223-16 of the AMF General Regulation) for listed companies to inform the market of their capital structure. It does not fit into specific categories like 'Major Shareholding Notification' (which tracks individual investors) or 'Share Issue' (which announces a change). As it is a mandatory regulatory disclosure regarding share capital and voting rights, it falls under the 'Regulatory Filings' (RNS) category.
2025-11-28 English
Informations privilégiées / Autres communiqués
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory announcement from Innate Pharma regarding the total number of shares and voting rights as of November 27, 2025. This is a standard periodic disclosure required by the French Financial Markets Authority (AMF) under articles L. 233-8 II of the Commercial Code and 223-16 of the AMF General Regulation. Since this document does not fit into specific categories like financial reports, dividends, or M&A, and serves as a mandatory regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2025-11-28 French
6-K
Foreign Filer Report
2025-11-17 English
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release announcing the company's participation in an upcoming investor conference (Jefferies Global Healthcare Conference). It provides details on the date, time, and location of the event, and includes a link to a webcast. It does not contain the actual presentation slides or a transcript of the event, nor is it a financial report. As it is a general regulatory announcement regarding corporate activities and investor relations, it falls under the RNS (Regulatory Filings) category.
2025-11-17 English
Informations privilégiées / Autres communiqués
Investor Presentation Classification · 1% confidence The document is a press release announcing that Innate Pharma will participate in the Jefferies Global Healthcare Conference. It provides details about the event, such as the date, time, and location, and mentions that the presentation will be available on their website. It does not contain the actual presentation slides or a transcript of the event, but rather serves as an announcement of the company's upcoming participation. According to the provided filing definitions and the 'Menu vs Meal' rule, this is a general regulatory announcement regarding company activities that does not fit into more specific categories like 'Investor Presentation' (which would be the slides themselves) or 'Call Transcript'. Therefore, it is classified as a Regulatory Filing (RNS).
2025-11-17 French
6-K
Foreign Filer Report
2025-11-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.